Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA

BACKGROUND: Epithelial ovarian cancer (EOC) is the most common type of ovarian tumor, however, effective treatment does not currently exist for this condition. This study evaluated the role of vitexin in mitigating EOC both in vitro and in vivo. METHOD: SKOV-3 cells were used for in vitro experiment...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shuzhen, Guan, Xinlei, Hou, Ruijie, Zhang, Xueying, Guo, Fang, Zhang, Zhifang, Hua, Caihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576048/
https://www.ncbi.nlm.nih.gov/pubmed/33240988
http://dx.doi.org/10.21037/atm-20-5586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576048/
https://www.ncbi.nlm.nih.gov/pubmed/33240988
http://dx.doi.org/10.21037/atm-20-5586

Ejemplares similares